EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

EMJ GOLD

Filter Advertise With Us
Illustration of scientific tools

New report calls for faster R&D for rare diseases

A report has found that while many in the UK live with rare diseases, systemic failures continue to restrict progress in treatment.

Spoonful of technology: April-June 2025

Explore the latest technology that is changing the pharma industry, and discover how these innovations could solve key health challenges.
The word spotlight on a blue background with the 'o' as a spotlight circle

Spotlight: June 2025

From new industry M&As to insights on how to recruit Gen Z talent, there’s plenty to discover in our latest pharma news round up.
Gold crown on blue background

AstraZeneca ranks top in science graduates' survey

Rising one place to number one overall, the British drugmaker has overtaken the NHS as the preferred destination for these graduates.
Handshake on green background

Bayer’s Stefan Oelrich elected as new EFPIA President

Stefan Oelrich has been newly elected President of the EFPIA, as new leadership calls for action to restore Europe’s global leadership in pharma innovation.
Hurdles on blue backgound

FDA removes hurdle to CAR T-cell therapies

The body is eliminating of Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed CAR T-cell therapies.
Purple briefcase on grey background

Sun Pharma appoints Richard Ascroft as North American CEO

Ascroft brings more than 30 years of industry experience, including senior roles at Takeda Pharmaceuticals.
Torn agreement

US withdraws funding from Gavi, the Vaccine Alliance

The US plans to stop its financial contributions to Gavi, the Vaccine Alliance, marking an end to an over 20-year partnership.
We’ve noticed you’re accessing
from North/South America.